The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis-Reference-Cited by-同舟云学术

The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis

Published:2022-09 Issue:14 Volume:82 Page:1469-1480
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Yang Shuo^ORCID,Zhao Lu,He Wei,Mi Yaochuan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-022-01779-z.pdf

Reference28 articles.

1. Meier RK. Polycystic ovary syndrome. Nurs Clin North Am. 2018;53(3):407–20.

2. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165–74.

3. Papaetis GS, Filippou PK, Constantinidou KG, Stylianou CS. Liraglutide: new perspectives for the treatment of polycystic ovary syndrome. Clin Drug Investig. 2020;40(8):695–713.

4. Toosy S, Sodi R, Pappachan JM. Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach. J Diabetes Metab Disord. 2018;17(2):277–85.

5. Street ME, Cirillo F, Catellani C, Dauriz M, Lazzeroni P, Sartori C, et al. current treatment for polycystic ovary syndrome: focus on adolescence. Minerva Pediatr. 2020;72(4):288–311.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-04-16

2. Comparative Effectiveness of Antidiabetic Drugs as an Additional Therapy to Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review of Metabolic Approaches;International Journal of Endocrinology;2024-03-11

3. Comparative effectiveness of glucagon-like peptide-1 receptor agonists on body composition and anthropometric indices: A protocol for a systematic review and network meta-analysis of randomized controlled trials;PLOS ONE;2024-02-26

4. Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome;Diabetes/Metabolism Research and Reviews;2023-07

5. Polycystic ovary syndrome as a gender-specific cardiometabolic risk factor;Die Innere Medizin;2023-06-08